abraxane
Showing 26 - 50 of 63
NSCLC, Recurrent, Adenocarcinoma of Lung Trial (Vargatef, Abraxane, )
Withdrawn
- NSCLC, Recurrent
- Adenocarcinoma of Lung
- Vargatef
- +2 more
- (no location specified)
Nov 20, 2020
Breast Cancer Trial in Worldwide (Abraxane, Paclitaxel)
Active, not recruiting
- Breast Cancer
- Abraxane
- Paclitaxel
-
Adelaide, South Australia, Australia
- +66 more
Aug 10, 2022
Adenocarcinoma of the Pancreas Trial in Philadelphia (Paricalcitol, Abraxane, Gemcitabine)
Completed
- Adenocarcinoma of the Pancreas
- Paricalcitol
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Apr 28, 2020
Pancreatic Ductal Adenocarcinoma Trial in Philadelphia (Pegvorhyaluronidase alfa, Abraxane, Gemcitabine)
Withdrawn
- Pancreatic Ductal Adenocarcinoma
- Pegvorhyaluronidase alfa
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center at University of Pennsylvania
Jan 30, 2020
Metastatic Breast Cancer Trial in Houston (T-DM1, Lapatinib, Abraxane)
Completed
- Metastatic Breast Cancer
- T-DM1
- +2 more
-
Houston, TexasHouston Methodist Hospital
Apr 12, 2019
Pancreatic Adenocarcinoma Trial in Cambridge (Abraxane, Gemcitabine)
Terminated
- Pancreatic Adenocarcinoma
- Abraxane
- Gemcitabine
-
Cambridge, United KingdomAddenbrookes Hospital
Jul 15, 2019
Pancreatic Cancer Trial in Pittsburgh (gemcitabine, abraxane, hydroxychloroquine)
Completed
- Pancreatic Cancer
- gemcitabine
- +2 more
-
Pittsburgh, PennsylvaniaHillman Cancer Center
Mar 25, 2019
Metastatic Pancreatic Cancer Trial in Munich (Afatinib 30Mg Tab, Afatinib 40Mg Tab, Gemzar)
Unknown status
- Metastatic Pancreatic Cancer
- Afatinib 30Mg Tab
- +3 more
-
Munich, GermanyLudwig-Maximilians - University of Munich
Aug 9, 2018
Breast Cancer, Lung Cancer, Solid Tumor Trial in Sacramento (Abraxane, Alimta)
Terminated
- Breast Cancer
- +2 more
- Abraxane
- Alimta
-
Sacramento, CaliforniaUniversity of California Davis Cancer Center
Jan 5, 2018
Male Breast Cancer, Recurrent Breast Cancer, Skin Metastases Trial in Seattle (drug, other, genetic)
Completed
- Male Breast Cancer
- +3 more
- imiquimod
- +4 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Dec 7, 2017
HER2-negative Breast Cancer, Inflammatory Breast Cancer, Male Breast Cancer Trial in Philadelphia (Romidepsin, Abraxane)
Terminated
- HER2-negative Breast Cancer
- +4 more
- Romidepsin
- Abraxane
-
Philadelphia, PennsylvaniaThomas Jefferson University
Dec 4, 2017
Squamous Cell Carcinoma of the Head and Neck, Basaloid Squamous Cell Carcinoma, Undifferentiated Carcinoma Trial (Abraxane,
Terminated
- Squamous Cell Carcinoma of the Head and Neck
- +3 more
- Abraxane
- +3 more
- (no location specified)
Oct 10, 2017
Head Neck Cancer Trial in Orange (Abraxane, Cetuximab)
Terminated
- Head and Neck Cancer
- Abraxane
- Cetuximab
-
Orange, CaliforniaChao Family Comprehensive Cancer Center
Jan 11, 2018
Small Cell Lung Cancer Trial in Chapel Hill (Carboplatin, Abraxane)
Terminated
- Small Cell Lung Cancer
- Carboplatin
- Abraxane
-
Chapel Hill, North CarolinaUniversity of North Carolina Lineberger Comprehensive Cancer Cen
Jun 9, 2017
Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in St. Louis (Abraxane)
Terminated
- Lymphoma, Non-Hodgkin
- Hodgkin Disease
- Abraxane
-
St. Louis, Missouri
- +1 more
Dec 5, 2016
Prostatic Tumors Trial in Houston (Abraxane, Leuprolide, Bicalutamide)
Terminated
- Prostatic Neoplasms
- Abraxane
- +2 more
-
Houston, TexasBaylor College of Medicine - Methodist Hospital
Mar 15, 2016
Pancreatic Cancer Trial in Cincinnati (Gemcitabine, Abraxane, Radiation Therapy)
Terminated
- Pancreatic Cancer
- Gemcitabine
- +2 more
-
Cincinnati, OhioUniversity of Cincinnati
Oct 23, 2015
Metastatic Breast Cancer Trial in Durham, Beijing (Abraxane, Carboplatin)
Metastatic Melanoma Trial (Abraxane)
Withdrawn
- Metastatic Melanoma
- Abraxane
- (no location specified)
Feb 3, 2014